BASI Profile
Bioanalytical Systems, Inc. (BASI) is a contract research organization (CRO) that provides preclinical and clinical drug development services to pharmaceutical, biotech, and medical device companies. The company offers a range of services, including pharmacokinetic and pharmacodynamic analysis, toxicology studies, analytical chemistry, and bioanalysis.
Bioanalytical Systems' services are designed to support drug development programs, from the early stages of research to clinical trials and regulatory submissions. The company operates a state-of-the-art laboratory facility in West Lafayette, Indiana, and has a team of experienced scientists and researchers who are dedicated to providing high-quality services to its clients.
Bioanalytical Systems is committed to providing innovative solutions to its clients and has a strong track record of delivering reliable and accurate data. The company has been in business for over 40 years and has established a reputation as a trusted partner for drug development companies.
As of February 2023, Bioanalytical Systems, Inc. (BASI) is still an active company, and its shares are traded on the NASDAQ stock exchange under the ticker symbol BASI. The company's commitment to quality and innovation make it a leader in the contract research industry, and it continues to provide valuable services to its clients in the pharmaceutical and biotech sectors.
|
